Latest Insider Transactions at Haemonetics Corp (HAE)
This section provides a real-time view of insider transactions for Haemonetics Corp (HAE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HAEMONETICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HAEMONETICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,073
-3.53%
|
$101,935
$95.0 P/Share
|
|
May 17
2024
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,439
+20.38%
|
-
|
|
May 17
2024
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,624
+5.23%
|
-
|
|
May 17
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,037
-1.59%
|
$383,515
$95.73 P/Share
|
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
733
-4.49%
|
$70,368
$96.04 P/Share
|
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-5.45%
|
$183,255
$95.47 P/Share
|
|
May 16
2024
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,410
+11.8%
|
$137,370
$57.6 P/Share
|
|
May 16
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
985
-3.14%
|
$94,560
$96.14 P/Share
|
|
May 16
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.4%
|
$41,924
$94.8 P/Share
|
|
May 16
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
770
-4.29%
|
$73,920
$96.14 P/Share
|
|
May 16
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
263
-1.44%
|
$24,722
$94.8 P/Share
|
|
May 16
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-1.62%
|
$21,902
$94.8 P/Share
|
|
May 16
2024
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-2.65%
|
$32,994
$94.8 P/Share
|
|
May 16
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,907
-0.74%
|
$179,258
$94.8 P/Share
|
|
May 16
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-2.66%
|
$29,892
$94.8 P/Share
|
|
May 15
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
241
-1.5%
|
$23,136
$96.49 P/Share
|
|
May 15
2024
|
Farris Maryanne Maunsell VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-11.59%
|
$7,008
$96.49 P/Share
|
|
May 15
2024
|
Roy Galvin President, Global Plasma & BC |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-4.5%
|
$20,544
$96.49 P/Share
|
|
May 15
2024
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-1.29%
|
$39,936
$96.49 P/Share
|
|
May 15
2024
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-1.4%
|
$24,768
$96.49 P/Share
|
|
May 15
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-1.59%
|
$22,368
$96.49 P/Share
|
|
May 15
2024
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-3.01%
|
$39,552
$96.49 P/Share
|
|
May 15
2024
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,480
-0.57%
|
$142,080
$96.49 P/Share
|
|
May 15
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-2.74%
|
$32,352
$96.49 P/Share
|
|
May 06
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,305
-15.79%
|
$218,975
$95.0 P/Share
|
|
May 02
2024
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
432
-3.06%
|
$40,176
$93.33 P/Share
|
|
Apr 15
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-1.27%
|
$15,456
$84.88 P/Share
|
|
Mar 11
2024
|
Simon, Christopher President & CEO |
SELL
Bona fide gift
|
Direct |
38,900
-13.12%
|
-
|
|
Nov 01
2023
|
Roy Galvin President, Global Plasma & BC |
SELL
Payment of exercise price or tax liability
|
Direct |
160
-3.36%
|
$13,760
$86.39 P/Share
|
|
Oct 20
2023
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
197
-0.61%
|
$17,533
$89.05 P/Share
|
|
Oct 20
2023
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-0.74%
|
$10,680
$89.05 P/Share
|
|
Sep 15
2023
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
209
-1.43%
|
$18,810
$90.11 P/Share
|
|
Sep 12
2023
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
228
-1.39%
|
$20,520
$90.65 P/Share
|
|
Sep 11
2023
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,305
-13.72%
|
$207,450
$90.0 P/Share
|
|
Sep 05
2023
|
Charles J Dockendorff Director |
SELL
Open market or private sale
|
Direct |
10,215
-82.11%
|
$888,705
$87.68 P/Share
|
|
Aug 04
2023
|
Diane M Bryant Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+50.0%
|
-
|
|
Aug 04
2023
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+15.18%
|
-
|
|
Aug 04
2023
|
Claire Pomeroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+15.68%
|
-
|
|
Aug 04
2023
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+13.33%
|
-
|
|
Aug 04
2023
|
Lloyd Emerson Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+21.7%
|
-
|
|
Aug 04
2023
|
Mark W Kroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+10.76%
|
-
|
|
Aug 04
2023
|
Robert E Abernathy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+9.98%
|
-
|
|
Aug 04
2023
|
Michael J Coyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,226
+17.5%
|
-
|
|
Jul 18
2023
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
4,928
-21.07%
|
$443,520
$90.0 P/Share
|
|
Jul 18
2023
|
Josep Llorens EVP, Global Manufacturing |
BUY
Exercise of conversion of derivative security
|
Direct |
4,928
+10.04%
|
$280,896
$57.08 P/Share
|
|
Jun 29
2023
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
117,667
-28.41%
|
$9,884,028
$84.84 P/Share
|
|
Jun 29
2023
|
Simon, Christopher President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
196,746
+32.21%
|
$5,508,888
$28.61 P/Share
|
|
Jun 07
2023
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
2,538
-13.37%
|
$223,344
$88.04 P/Share
|
|
Jun 07
2023
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-21.02%
|
$444,664
$88.0 P/Share
|
|
Jun 07
2023
|
Stewart W Strong President, Global Hospital |
BUY
Exercise of conversion of derivative security
|
Direct |
6,893
+13.14%
|
$392,901
$57.08 P/Share
|